Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2012-12-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study 40 patients will be studied; 20 patients in every group. Besides the general data as length, weight, age, abdominal circumference, volume of the legs additional muscle strength and physical fitness of women with lipedema and women with obesity will be measured and analysis.
This study doesn't involve a negligible risk for participants. The study will not have direct benefit for the participants, but may be useful in giving more clarity in defining the phenotype for patients with lipedema.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patient with lipoedema
Lipedema group:
* diagnosed with lipedema following the criteria of Wold
* women
* age ≥ 18 years
clinimetrics: volume, muscle strength, physical condition, BMI
volume, muscle strength, physical condition, BMI
phys. condition, muscle strength, volumetry, BMI
patients with obesity
Obesity group:
* BMI ≥ 30
* women
* age ≥ 18 years
clinimetrics: volume, muscle strength, physical condition, BMI
volume, muscle strength, physical condition, BMI
phys. condition, muscle strength, volumetry, BMI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
volume, muscle strength, physical condition, BMI
phys. condition, muscle strength, volumetry, BMI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Lipedema group:
* diagnosed with lipedema following the criteria of Wold et al3
* women
* age ≥ 18 years
Obesity group:
* BMI ≥ 30
* women
* age ≥ 18 years
Exclusion Criteria
Lipedema group:
\- none
Obesity group:
\- an obesity intervention with physical training in the ≤12 months prior to the measurement
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nij Smellinghe Hosptial
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
R.J. Damstra
Dermatologist MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
RJ Damstra, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Nij Smellinghe Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Expert Center for Lymphovascular Medicine Nij Smellinghe Hospital
Drachten, Provincie Friesland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
General website form the Nij Smellinghe hospital
The foundation related to the expert centre organizing research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nij Smellinghe hospital
Identifier Type: OTHER
Identifier Source: secondary_id
NS4NL
Identifier Type: -
Identifier Source: org_study_id